The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Development
The EMBO Journal (2006) 25, 5201–5213, doi:10.1038/sj.emboj.7601379
Published online 19 October 2006
The Kruppel-like transcription factor KLF13 is a novel regulator of heart development
Geneviève Lavallée1, 2, 3, Gregor Andelfinger1, 2, 3, Mathieu Nadeau1, 2, Chantal Lefebvre1, 2, Georges Nemer1, 2, 4, Marko E Horb1, 2 and Mona Nemer1, 2
1 Institut de recherches cliniques de Montréal (IRCM), Montréal, Quebec, Canada
2 Université de Montréal, Montréal, Quebec, Canada

To whom correspondence should be addressed

Mona Nemer, Cardiac Growth and Differentiation Unit, Institut de recherches cliniques de Montréal (IRCM), 110, avenue des Pins Ouest, Montréal, Quebec, Canada H2W 1R7. Tel.: +1 514 987 5680; Fax: +1 514 987 5575; E-mail: mona.nemer@ircm.qc.ca
Marko E Horb, Cardiac Growth and Differentiation Unit, Institut de recherches cliniques de Montréal (IRCM), 110, avenue des Pins Ouest, Montréal, Quebec, Canada H2W 1R7. Tel.: +1 514 987 5680; Fax: +1 514 987 5575; E-mail: marko.horb@ircm.qc.ca

3 These authors contributed equally to this work
4 Present address: Faculty of Medicine, American University of Beirut, Lebanon

Received 7 April 2006; Accepted 6 September 2006; Published online 19 October 2006.
Abstract
In humans, congenital heart defects occur in 1–2% of live birth, but the molecular mechanisms and causative genes remain unidentified in the majority of cases. We have uncovered a novel transcription pathway important for heart morphogenesis. We report that KLF13, a member of the Krüppel-like family of zinc-finger proteins, is expressed predominantly in the heart, binds evolutionarily conserved regulatory elements on cardiac promoters and activates cardiac transcription. KLF13 is conserved across species and knockdown of KLF13 in Xenopus embryos leads to atrial septal defects and hypotrabeculation similar to those observed in humans or mice with hypomorphic GATA-4 alleles. Physical and functional interaction with GATA-4, a dosage-sensitive cardiac regulator, provides a mechanistic explanation for KLF13 action in the heart. The data demonstrate that KLF13 is an important component of the transcription network required for heart development and suggest that KLF13 is a GATA-4 modifier; by analogy to other GATA-4 collaborators, mutations in KLF13 may be causative for congenital human heart disease.
Keywords: ANP, BNP, cardiac transcription, GATA-4, Xenopus
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Getting the T-box dose right

Nature Medicine News and Views (01 Nov 2001)

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization